Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Evaluation of whole genome sequencing and software tools for drug susceptibility testing of Mycobacterium tuberculosis.

van Beek J, Haanperä M, Smit PW, Mentula S, Soini H.

Clin Microbiol Infect. 2019 Jan;25(1):82-86. doi: 10.1016/j.cmi.2018.03.041. Epub 2018 Apr 11.

PMID:
29653190
2.

Lactobacillus reuteri to Treat Infant Colic: A Meta-analysis.

Sung V, D'Amico F, Cabana MD, Chau K, Koren G, Savino F, Szajewska H, Deshpande G, Dupont C, Indrio F, Mentula S, Partty A, Tancredi D.

Pediatrics. 2018 Jan;141(1). pii: e20171811. doi: 10.1542/peds.2017-1811. Review.

3.

The recognition and characterisation of Finnish Clostridium difficile isolates resembling PCR-ribotype 027.

Krutova M, Nyc O, Matejkova J, Kuijper EJ, Jalava J, Mentula S.

J Microbiol Immunol Infect. 2018 Jun;51(3):344-351. doi: 10.1016/j.jmii.2017.02.002. Epub 2017 May 24.

4.

Clostridium difficile infections in Finland, 2008-2015: trends, diagnostics and ribotypes.

Mentula S, Kotila SM, Lyytikäinen O, Ibrahem S, Ollgren J, Virolainen A.

Eur J Clin Microbiol Infect Dis. 2017 Oct;36(10):1939-1945. doi: 10.1007/s10096-017-3017-5. Epub 2017 May 30.

PMID:
28555402
5.

Community- and Healthcare-Associated Clostridium difficile Infections, Finland, 2008-2013(1).

Kotila SM, Mentula S, Ollgren J, Virolainen-Julkunen A, Lyytikäinen O.

Emerg Infect Dis. 2016 Oct;22(10):1747-53. doi: 10.3201/eid2210.151492.

6.

Standardised surveillance of Clostridium difficile infection in European acute care hospitals: a pilot study, 2013.

van Dorp SM, Kinross P, Gastmeier P, Behnke M, Kola A, Delmée M, Pavelkovich A, Mentula S, Barbut F, Hajdu A, Ingebretsen A, Pituch H, Macovei IS, Jovanović M, Wiuff C, Schmid D, Olsen KE, Wilcox MH, Suetens C, Kuijper EJ; European Clostridium difficile Infection Surveillance Network (ECDIS-Net) on behalf of all participants.

Euro Surveill. 2016 Jul 21;21(29). doi: 10.2807/1560-7917.ES.2016.21.29.30293.

7.

Survey of diagnostic and typing capacity for Clostridium difficile infection in Europe, 2011 and 2014.

van Dorp SM, Notermans DW, Alblas J, Gastmeier P, Mentula S, Nagy E, Spigaglia P, Ivanova K, Fitzpatrick F, Barbut F, Morris T, Wilcox MH, Kinross P, Suetens C, Kuijper EJ; European Clostridium difficile Infection Surveillance Network (ECDIS-Net) project on behalf of all participants.

Euro Surveill. 2016 Jul 21;21(29). doi: 10.2807/1560-7917.ES.2016.21.29.30292.

8.

Differentiating virulent 027 and non-027 Clostridium difficile strains by molecular methods.

Mentula S, Laakso S, Lyytikäinen O, Kirveskari J.

Expert Rev Mol Diagn. 2015;15(9):1225-9. doi: 10.1586/14737159.2015.1069710. Epub 2015 Aug 4.

PMID:
26289601
9.

Regional differences in Clostridium difficile infections in relation to fluoroquinolone and proton pump inhibitor use, Finland, 2008-2011.

Kanerva M, Ollgren J, Voipio T, Mentula S, Lyytikäinen O.

Infect Dis (Lond). 2015 Aug;47(8):530-5. doi: 10.3109/23744235.2015.1026933. Epub 2015 Apr 2.

PMID:
25832317
10.

Lactobacillus reuteri DSM 17938 for managing infant colic: protocol for an individual participant data meta-analysis.

Sung V, Cabana MD, D'Amico F, Deshpande G, Dupont C, Indrio F, Mentula S, Partty A, Savino F, Szajewska H, Tancredi D.

BMJ Open. 2014 Dec 4;4(12):e006475. doi: 10.1136/bmjopen-2014-006475. Review.

11.

Underdiagnosis of Clostridium difficile across Europe: the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID).

Davies KA, Longshaw CM, Davis GL, Bouza E, Barbut F, Barna Z, Delmée M, Fitzpatrick F, Ivanova K, Kuijper E, Macovei IS, Mentula S, Mastrantonio P, von Müller L, Oleastro M, Petinaki E, Pituch H, Norén T, Nováková E, Nyč O, Rupnik M, Schmid D, Wilcox MH.

Lancet Infect Dis. 2014 Dec;14(12):1208-19. doi: 10.1016/S1473-3099(14)70991-0. Epub 2014 Nov 7.

12.

Legionella longbeachae infection in a persistent hand-wound after a gardening accident.

Mentula S, Pentikäinen J, Perola O, Ruotsalainen E.

JMM Case Rep. 2014 Dec 1;1(4):e004374. doi: 10.1099/jmmcr.0.004374. eCollection 2014 Dec.

13.

Evaluation of a new automated homogeneous PCR assay, GenomEra C. difficile, for rapid detection of Toxigenic Clostridium difficile in fecal specimens.

Hirvonen JJ, Mentula S, Kaukoranta SS.

J Clin Microbiol. 2013 Sep;51(9):2908-12. doi: 10.1128/JCM.01083-13. Epub 2013 Jun 26.

14.

Reduction in Clostridium difficile infections in Finland, 2008-2010.

Kanerva M, Mentula S, Virolainen-Julkunen A, Kärki T, Möttönen T, Lyytikäinen O; Hospital Infection Surveillance Team.

J Hosp Infect. 2013 Feb;83(2):127-31. doi: 10.1016/j.jhin.2012.09.021. Epub 2012 Nov 30.

PMID:
23201398
15.

Two Legionnaires' disease cases associated with industrial waste water treatment plants: a case report.

Kusnetsov J, Neuvonen LK, Korpio T, Uldum SA, Mentula S, Putus T, Tran Minh NN, Martimo KP.

BMC Infect Dis. 2010 Dec 2;10:343. doi: 10.1186/1471-2334-10-343.

16.

Detection of virulence genes of Clostridium difficile by multiplex PCR.

Antikainen J, Pasanen T, Mero S, Tarkka E, Kirveskari J, Kotila S, Mentula S, Könönen E, Virolainen-Julkunen AR, Vaara M, Tissari P.

APMIS. 2009 Aug;117(8):607-13. doi: 10.1111/j.1600-0463.2009.02509.x.

PMID:
19664132
17.

Diagnostic trends in Clostridium difficile detection in Finnish microbiology laboratories.

Könönen E, Rasinperä M, Virolainen A, Mentula S, Lyytikäinen O.

Anaerobe. 2009 Dec;15(6):261-5. doi: 10.1016/j.anaerobe.2009.06.008. Epub 2009 Jul 8.

PMID:
19591954
18.

P1A recombinant beta-lactamase prevents emergence of antimicrobial resistance in gut microflora of healthy subjects during intravenous administration of ampicillin.

Tarkkanen AM, Heinonen T, Jõgi R, Mentula S, van der Rest ME, Donskey CJ, Kemppainen T, Gurbanov K, Nord CE.

Antimicrob Agents Chemother. 2009 Jun;53(6):2455-62. doi: 10.1128/AAC.00853-08. Epub 2009 Mar 23.

19.

First isolation of Clostridium difficile PCR ribotype 027 in Finland.

Lyytikäinen O, Mentula S, Könönen E, Kotila S, Tarkka E, Anttila VJ, Mattila E, Kanerva M, Vaara M, Valtonen V.

Euro Surveill. 2007 Nov 8;12(11):E071108.2. No abstract available.

20.

Relatedness of Escherichia coli strains with different susceptibility patterns isolated from beagle dogs during ampicillin treatment.

Mentula S, Virtanen T, Kanervo-Nordström A, Harmoinen J, Westermarck E, Rautio M, Huovinen P, Könönen E.

Int J Antimicrob Agents. 2006 Jan;27(1):46-50.

PMID:
16324827
21.

Comparison between cultured small-intestinal and fecal microbiotas in beagle dogs.

Mentula S, Harmoinen J, Heikkilä M, Westermarck E, Rautio M, Huovinen P, Könönen E.

Appl Environ Microbiol. 2005 Aug;71(8):4169-75.

22.

Inhibition of ampicillin-induced emergence of resistance in intestinal coliforms by targeted recombinant beta-lactamase.

Mentula S, Harmoinen J, Koski P, Westermarck E, Rautio M, Huovinen P, Könönen E.

Int J Antimicrob Agents. 2004 Dec;24(6):555-61.

PMID:
15555877
23.

Orally administered targeted recombinant Beta-lactamase prevents ampicillin-induced selective pressure on the gut microbiota: a novel approach to reducing antimicrobial resistance.

Harmoinen J, Mentula S, Heikkilä M, van der Rest M, Rajala-Schultz PJ, Donskey CJ, Frias R, Koski P, Wickstrand N, Jousimies-Somer H, Westermarck E, Lindevall K.

Antimicrob Agents Chemother. 2004 Jan;48(1):75-9.

24.

Factors associated with ileal mucosal morphology and inflammation in patients with ileal pouch-anal anastomosis for ulcerative colitis.

Kuisma J, Mentula S, Luukkonen P, Jarvinen H, Kahri A, Farkkila M.

Dis Colon Rectum. 2003 Nov;46(11):1476-83.

PMID:
14605565
25.

Effect of Lactobacillus rhamnosus GG on ileal pouch inflammation and microbial flora.

Kuisma J, Mentula S, Jarvinen H, Kahri A, Saxelin M, Farkkila M.

Aliment Pharmacol Ther. 2003 Feb 15;17(4):509-15.

26.

Designation of the European Working Group on Legionella Infection (EWGLI) amplified fragment length polymorphism types of Legionella pneumophila serogroup 1 and results of intercentre proficiency testing Using a standard protocol.

Fry NK, Bangsborg JM, Bergmans A, Bernander S, Etienne J, Franzin L, Gaia V, Hasenberger P, Baladrón Jiménez B, Jonas D, Lindsay D, Mentula S, Papoutsi A, Struelens M, Uldum SA, Visca P, Wannet W, Harrison TG.

Eur J Clin Microbiol Infect Dis. 2002 Oct;21(10):722-8. Epub 2002 Sep 26.

PMID:
12415471
27.

Pan-European study on culture-proven Legionnaires' disease: distribution of Legionella pneumophila serogroups and monoclonal subgroups.

Helbig JH, Bernander S, Castellani Pastoris M, Etienne J, Gaia V, Lauwers S, Lindsay D, Lück PC, Marques T, Mentula S, Peeters MF, Pelaz C, Struelens M, Uldum SA, Wewalka G, Harrison TG.

Eur J Clin Microbiol Infect Dis. 2002 Oct;21(10):710-6. Epub 2002 Oct 18.

PMID:
12415469
28.

A newborn with domestically acquired legionnaires disease confirmed by molecular typing.

Skogberg K, Nuorti JP, Saxen H, Kusnetsov J, Mentula S, Fellman V, Mäki-Petäys N, Jousimies-Somer H.

Clin Infect Dis. 2002 Oct 15;35(8):e82-5. Epub 2002 Sep 19.

PMID:
12355396
29.

Ethanol-derived microbial production of carcinogenic acetaldehyde in achlorhydric atrophic gastritis.

Väkeväinen S, Mentula S, Nuutinen H, Salmela KS, Jousimies-Somer H, Färkkilä M, Salaspuro M.

Scand J Gastroenterol. 2002 Jun;37(6):648-55.

PMID:
12126241

Supplemental Content

Loading ...
Support Center